Discontinued — last reported Q3 '24
Procter & Gamble Corporate — Net Sales decreased by 19.7% to $163.00M in Q3 2024 compared to the prior quarter. Year-over-year, this metric grew by 13.2%, from $144.00M to $163.00M. Over 3 years (FY 2021 to FY 2024), Corporate — Net Sales shows an upward trend with a 10.9% CAGR.
An increase may reflect changes in intercompany eliminations or specific corporate-level revenue streams, while a decrease often indicates reduced corporate-level adjustments or shifts in consolidation accounting.
This metric represents the total revenue generated by the corporate segment, typically encompassing centralized activiti...
Most large conglomerates report a similar 'Corporate' or 'Other' segment to reconcile consolidated revenue with operating segment totals.
pg_segment_corporate_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $126.00M | $138.00M | $152.00M | $215.00M | $239.00M | $253.00M | $175.00M | $173.00M | $164.00M | $144.00M | $126.00M | $128.00M | $203.00M | $163.00M |
| QoQ Change | — | +9.5% | +10.1% | +41.4% | +11.2% | +5.9% | -30.8% | -1.1% | -5.2% | -12.2% | -12.5% | +1.6% | +58.6% | -19.7% |
| YoY Change | — | — | — | — | +89.7% | +83.3% | +15.1% | -19.5% | -31.4% | -43.1% | -28.0% | -26.0% | +23.8% | +13.2% |